Abstract
Whereas the usual way to gain access to the vascular bed for hemodialysis is by inserting two needles, an alternative option based on the introduction of only one needle has been available for several decades. Although single needle hemodialysis gradually lost popularity in the early nineties of last century, this option now seems to make a come-back, with the current change in patient mix towards more elderly and cardio-vascular disease and the appearance of more flexible hardware. Single needle hemodialysis offers several advantages, such as the possibility to puncture small or maturing access systems, a decrease in number of punctures with less potential access damage and subsequent complications, the avoidance of central vein catheter use, and an improved quality of life by reducing puncture-related pain, stress and complications. The main drawback is recirculation which however can be overcome (if considered necessary) by making dialysis somewhat longer and in addition has more impact on removal of small water soluble compounds than on clearance of the more toxic difficult to remove solutes (middle molecules and protein bound compounds). Effective dialyzer blood flow with single needle dialysis cannot be much higher than 300 mL/min, which however also offers advantages by making short dialysis sessions less feasible and thus reducing the likelihood of intradialytic blood pressure falls, organ stunning and other negative outcomes of shorter dialysis. Direct outcome comparisons between single and double needle dialysis are not available but indirect data suggest no differences, in as far as efficient enough access perfusion can keep dialyzer blood flow adequate. The single needle method seems especially suited for the elderly and for home hemodialysis. Recent technological improvements have made the system more accessible and adequate, but further studies are needed to assess with modern methodologies the clearance kinetics of these systems, which could emanate in further technological fine-tuning.
Similar content being viewed by others
References
Kopp KF, Gutch CF, Kolff WJ (1972) Single needle dialysis. Trans Am Soc Artif Intern Organs 18:75–81
Vanholder R, Hoenich NA, Ringoir S (1989) Single needle haemodialysis. In: Maher JF (ed) Replacement of renal function by dialysis. Kluwer Academic Publishers, Dordrecht, pp 382–399
Bieser W, Welsch M, Jakob M et al (2018) Effectiveness of a new single-needle single-pump dialysis system with simultaneous monitoring of dialysis dose. Artif Organs 42(8):814–823
Konner K, Nonnast-Daniel B, Ritz E (2003) The arteriovenous fistula. J Am Soc Nephrol 14(6):1669–1680
van Loon MM, Kessels AG, Van der Sande FM, Tordoir JH (2009) Cannulation and vascular access-related complications in hemodialysis: factors determining successful cannulation. Hemodial Int Int Symp Home Hemodial 13(4):498–504
Ervo R (2013) Novita nella dialisi at ago singolo. G Ital Nefrol 30(3):1–11
Tordoir JH, van Loon MM, Peppelenbosch N, Bode AS, Poeze M, van der Sande FM (2010) Surgical techniques to improve cannulation of hemodialysis vascular access. Eur J Vasc Endovasc Surg 39(3):333–339
Gallieni M, Hollenbeck M, Inston N et al (2019) Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults. Nephrol Dial Transplant 34(Suppl 2):ii1–ii42
Vanholder R, Van Biesen W, Fox JG, Nagler EV (2019) The new European Renal Best Practice guideline on arteriovenous access: why worthwhile to read. Nephrol Dial Transplant 34(7):1071–1074
Siddiqui MA, Ashraff S, Carline T (2017) Maturation of arteriovenous fistula: analysis of key factors. Kidney Res Clin Pract 36(4):318–328
Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN (2007) A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg 45(2):420–426
Ceretta ML, Noordzij M, Luxardo R et al (2018) Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry. Nephrol Dial Transplant 33(10):1794–1804
Kurella M, Covinsky KE, Collins AJ, Chertow GM (2007) Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146(3):177–183
Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK (2001) Type of vascular access and mortality in US hemodialysis patients. Kidney Int 60(4):1443–1451
Pastan S, Soucie JM, McClellan WM (2002) Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62(2):620–626
Rayner HC, Pisoni RL, Gillespie BW et al (2003) Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 63(1):323–330
Moon JY, Lee HM, Lee SH et al (2015) Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis. Kidney Res Clin Pract 34(1):41–46
Parisotto MT, Pelliccia F, Grassmann A, Marcelli D (2017) Elements of dialysis nursing practice associated with successful cannulation: result of an international survey. J Vasc Access 18(2):114–119
Lee T, Barker J, Allon M (2006) Needle infiltration of arteriovenous fistulae in hemodialysis: risk factors and consequences. Am J Kidney Dis 47(6):1020–1026
Group FHNT, Chertow GM, Levin NW et al (2010) In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287–2300
Vanholder R, Hoenich N, Ringoir S (1987) Adequacy studies of fistula single-needle dialysis. Am J Kidney Dis 10(6):417–426
De Clippele M, Vanholder R, De Roose J, Derom F, Ringoir S (1983) Fistula survival in single needle hemodialysis. Int J Artif Organs 6(2):71–73
Wilson B, Harwood L, Thompson B (2009) Impact of single-needle therapy in new chronic hemodialysis starts for individuals with arteriovenous fistulae. CANNT J 19(2):23–28
Xue JL, Dahl D, Ebben JP, Collins AJ (2003) The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 42(5):1013–1019
Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS (2017) The survival benefit of “Fistula First, Catheter Last” in hemodialysis is primarily due to patient factors. J Am Soc Nephrol 28(2):645–652
Menon V, Greene T, Wang X et al (2005) C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 68(2):766–772
Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000) C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35(3):469–476
Goldstein SL, Ikizler TA, Zappitelli M, Silverstein DM, Ayus JC (2009) Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int 76(10):1063–1069
Manns B, Hemmelgarn B, Lillie E et al (2014) Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephrol 9(10):1813–1821
Viecelli AK, Tong A, O’Lone E et al (2018) Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop on establishing a core outcome measure for hemodialysis vascular access. Am J Kidney Dis 71(5):690–700
Viecelli AK, O’Lone E, Sautenet B et al (2018) Vascular access outcomes reported in maintenance hemodialysis trials: a systematic review. Am J Kidney Dis 71(3):382–391
Bay WH, Van Cleef S, Owens M (1998) The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol 18(5):379–383
Taylor MJ, Hanson CS, Casey JR, Craig JC, Harris D, Tong A (2016) “You know your own fistula, it becomes a part of you”—patient perspectives on vascular access: a semistructured interview study. Hemodial Int Int Symp Home Hemodial 20(1):5–14
Viecelli A, Howell M, Tong A et al (2019) Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfz148
Vanholder R, Hoenich N, Bogaert AM, Ringoir S (1986) Long-term experience with routine single-needle dialysis. A review. ASAIO Trans 32(1):300–304
Meijer JH, Reulen JP, Schneider H, Oe PL, Koolen MI (1979) Analysis of recirculation in single-needle haemodialysis. Med Biol Eng Comput 17(5):578–582
Ringoir S, Piron M, Vanholder R (1984) Conventional single needle hemodialysis. In: Ringoir S, Vanholder R, Ivanovich P (eds) First international symposium on single-needle dialysis. ISAO Press, Cleveland, pp 80–88
Saran R, Bragg-Gresham JL, Levin NW et al (2006) Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69(7):1222–1228
Flythe JE, Curhan GC, Brunelli SM (2013) Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain. Clin J Am Soc Nephrol 8(7):1151–1161
Flythe JE, Curhan GC, Brunelli SM (2013) Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int 83(1):104–113
Burton JO, Jefferies HJ, Selby NM, McIntyre CW (2009) Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4(5):914–920
Eldehni MT, Odudu A, McIntyre CW (2015) Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol 26(4):957–965
Eloot S, Van Biesen W, Dhondt A et al (2008) Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73(6):765–770
Blumenthal SS, Ortiz MA, Kleinman JG, Piering WF (1986) Inflow time and recirculation in single-needle hemodialysis. Am J Kidney Dis 8(3):202–206
Vanholder R, Hoenich N, Ringoir S (1982) Dialysis performance of single lumen subclavian hemodialysis: a comparative study with single lumen fistula hemodialysis. Artif Organs 6(4):429–432
Vanholder RHN, Piron M, Billiouw JM, Ringoir S (1983) Haemodialysis in a single and a two needle vascular access system: a comparative study. Proc Eur Dial Transplant Assoc 20:176–180
Vanholder R, Pletinck A, Schepers E, Glorieux G (2018) Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update. Toxins 10(1):33
Evenepoel P, Rodriguez M, Ketteler M (2014) Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease? Semin Nephrol 34(2):151–163
DeSoi CA, Umans JG (1993) Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol 4(5):1214–1218
Rostoker G, Griuncelli M, Loridon C, Bourlet T, Welsch K, Benmaadi A (2009) Improving the efficiency of short-term single-needle hemodialysis. Ren Fail 31(4):261–266
Tattersall J (2017) Hemodialysis time and Kt/V: less may be better. Semin Dial 30(1):10–14
Tattersall J (2013) Do we need another Kt/V? Nephrol Dial Transpl 28(8):1963–1966
Vanholder R, Glorieux G, Eloot S (2015) Once upon a time in dialysis: the last days of Kt/V? Kidney Int 88(3):460–465
Vanholder R, Van Biesen W, Lameire N (2019) A swan song for Kt/Vurea. Semin Dial 32(5):424–437
Basile C, Lomonte C (2012) Kt/V urea does not tell it all. Nephrol Dial Transplant 27(4):1284–1287
Gotch FA, Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28(3):526–534
Tattersall J, Martin-Malo A, Pedrini L et al (2007) EBPG guideline on dialysis strategies. Nephrol Dial Transplant 22(Suppl 2):ii5–ii21
Ervo R (2011) Extracorporeal dialysis: techniques and adequacy. NDT Plus 4(suppl 2):4.s2.37
Trakarnvanich T, Chirananthavat T, Ariyakulnimit S, Maneerat P, Chabsuwan S (2006) The efficacy of single-needle versus double-needle hemodialysis in chronic renal failure. J Med Assoc Thai 89(Suppl 2):S196–S206
Trakarnvanich T, Chirananthavat T, Maneerat P, Chabsuwan S, Areeyakulnimit S (2007) Is single-needle hemodialysis still a good treatment in end-stage renal disease? Blood Purif 25(5–6):490–496
Dhaene M, Gulbis B, Lietaer N et al (1989) Red blood cell destruction in single-needle dialysis. Clin Nephrol 31(6):327–331
Kumar S, Bandyopadhyay U (2005) Free heme toxicity and its detoxification systems in human. Toxicol Lett 157(3):175–188
Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM (2013) Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 121(8):1276–1284
Grooteman MP, van den Dorpel MA, Bots ML et al (2012) Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23(6):1087–1096
Morena M, Jaussent A, Chalabi L et al (2017) Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int 91(6):1495–1509
Maduell F, Moreso F, Pons M et al (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24(3):487–497
Ok E, Asci G, Toz H et al (2013) Mortality and cardiovascular events in online hemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 28(1):192–202
Lowrie EG, Laird NM, Parker TF, Sargent JA (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305(20):1176–1181
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Raymond Vanholder received travel support and speakers honoraria from BBraun.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vanholder, R. Single needle hemodialysis: is the past the future?. J Nephrol 33, 49–58 (2020). https://doi.org/10.1007/s40620-019-00644-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-019-00644-9